Methods for administering tumor vaccines
    1.
    发明申请
    Methods for administering tumor vaccines 审中-公开
    肿瘤疫苗的使用方法

    公开(公告)号:US20080124354A1

    公开(公告)日:2008-05-29

    申请号:US11822870

    申请日:2007-07-10

    摘要: The present invention provides methods of inducing an immune response in a subject against a protein of interest and treating and suppressing a formation of a tumor comprising a tumor-associated protein, comprising sequential administration of fragments of the protein. The present invention also provides Her-2 protein fragments, recombinant peptides comprising same, nucleotide molecules encoding same, recombinant vaccine vectors and immunogenic compositions comprising same, and methods for inducing immune response and treating cancer, comprising same.

    摘要翻译: 本发明提供了针对目的蛋白质诱导受试者的免疫应答的方法,并且治疗和抑制包含肿瘤相关蛋白的肿瘤的形成,包括顺序施用蛋白质的片段。 本发明还提供了Her-2蛋白片段,包含其的重组肽,编码它们的核苷酸分子,重组疫苗载体和包含其的免疫原性组合物,以及诱导免疫应答和治疗癌症的方法。

    Listeria-based and LLO-based vaccines
    4.
    发明申请
    Listeria-based and LLO-based vaccines 有权
    基于李斯特菌和基于LLO的疫苗

    公开(公告)号:US20060093582A1

    公开(公告)日:2006-05-04

    申请号:US11223945

    申请日:2005-09-13

    IPC分类号: A61K48/00 A61K39/02

    摘要: This invention provides methods of treating and vaccinating against an antigen-expressing tumor and inducing an immune response against a sub-dominant epitope of antigen, comprising a fusion of an LLO fragment to the antigen or a recombinant Listeria strain expressing the antigen. The present invention also provides recombinant peptides comprising a listeriolysin (LLO) protein fragment fused to a Her-2 protein or fragment thereof, recombinant Listeria strains expressing a Her-2 protein, vaccines and immunogenic compositions comprising same, and methods of inducing an anti-Her-2 immune response and treating and vaccinating against a Her-2-expressing tumor, comprising same.

    摘要翻译: 本发明提供了针对抗原表达的肿瘤治疗和接种疫苗并针对抗原的亚优势表位诱导免疫应答的方法,其包括LLO片段与抗原或表达抗原的重组利斯特氏菌属菌株的融合物。 本发明还提供了包含与Her-2蛋白或其片段融合的李斯特里菌素(LLO)蛋白片段,表达Her-2蛋白的重组利斯特氏菌菌株,疫苗和包含其的免疫原性组合物的重组肽, Her-2免疫应答,并针对Her-2表达的肿瘤进行治疗和接种疫苗,包括其。

    Listeria-based and LLO-based vaccines
    7.
    发明授权
    Listeria-based and LLO-based vaccines 有权
    基于李斯特菌和基于LLO的疫苗

    公开(公告)号:US07820180B2

    公开(公告)日:2010-10-26

    申请号:US11223945

    申请日:2005-09-13

    IPC分类号: A61K39/02 A61K38/04 A61K38/16

    摘要: This invention provides methods of treating and vaccinating against an antigen-expressing tumor and inducing an immune response against a sub-dominant epitope of antigen, comprising a fusion of an LLO fragment to the antigen or a recombinant Listeria strain expressing the antigen. The present invention also provides recombinant peptides comprising a listeriolysin (LLO) protein fragment fused to a Her-2 protein or fragment thereof, recombinant Listeria strains expressing a Her-2 protein, vaccines and immunogenic compositions comprising same, and methods of inducing an anti-Her-2 immune response and treating and vaccinating against a Her-2-expressing tumor, comprising same.

    摘要翻译: 本发明提供了针对抗原表达的肿瘤治疗和接种疫苗并针对抗原的亚优势表位诱导免疫应答的方法,其包括LLO片段与抗原或表达抗原的重组利斯特氏菌属菌株的融合物。 本发明还提供了包含与Her-2蛋白或其片段融合的李斯特里菌素(LLO)蛋白片段,表达Her-2蛋白的重组利斯特氏菌菌株,疫苗和包含其的免疫原性组合物的重组肽, Her-2免疫应答,并针对Her-2表达的肿瘤进行治疗和接种疫苗,包括其。